Hans Petter Eikesdal's picture
Hans Petter
Eikesdal
Researcher
Visit Address: 
Haukeland universitetssykehus, Laboratoriebygget
5021 Bergen
Postal Address: 
Postboks 7804
5021 Bergen
Phone: 
+47 55 58 67 36
+47 55 58 63 73
E-mail: 
Hans.Eikesdal@k2.uib.no
Download vCard
Journal articles
  • Austreid, Eilin; Lønning, Per Eystein; Eikesdal, Hans Petter. 2014. The emergence of targeted drugs in breast cancer to prevent resistance to endocrine treatment and chemotherapy. Expert Opinion on Pharmacotherapy. 15: 681-700. doi: 10.1517/14656566.2014.885952
  • Johannessen, Tor-Christian Aase; Wagner, Marek; Straume, Oddbjørn; Bjerkvig, Rolf; Eikesdal, Hans Petter. 2013. Tumor vasculature: the Achilles' heel of cancer? Expert opinion on therapeutic targets. 17: 7-20. doi: 10.1517/14728222.2013.730522
  • Lønning, Per Eystein; Eikesdal, Hans Petter. 2013. Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved. Endocrine-Related Cancer. 20: R183-R201. doi: 10.1530/ERC-13-0099
  • Storaas, Eivind; Holmaas, Gunhild; Gravdal, Karsten; Børretzen, Astrid; Eikesdal, Hans Petter. 2013. Lethal pneumonitis after docetaxel chemotherapy: Case report and review of the literature. Acta Oncologica. 52: 1034-1040. doi: 10.3109/0284186X.2012.750734
  • Schuster, Cornelia; Eikesdal, Hans Petter; Puntervoll, Hanne Eknes; Geisler, Jürgen; Geisler, Stephanie; Heinrich, Daniel; Molven, Anders; Lønning, Per Eystein; Akslen, Lars A.; Straume, Oddbjørn. 2012. Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension. PLoS ONE. 7. 8 pages. doi: 10.1371/journal.pone.0038364
  • Eikesdal, Hans Petter; Kalluri, Raghu. 2009. Drug resistance associated with antiangiogenesis therapy. Seminars in Cancer Biology. 19: 310-317.
  • Eikesdal, Hans Petter; Sugimoto, Hikaru; Birrane, Gabriel; Maeshima, Yohei; Cooke, Vesselina; Kieran, Mark; Kalluri, Raghu. 2008. Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor therapy. Proceedings of the National Academy of Science of the United States of America. 105: 15040-15045.
  • Niclou, SP; Danzeisen, C; Brons, NHC; Eikesdal, Hans Petter; Enger, Per Øyvind; Bjerkvig, Rolf. 2008. COMPLETE SEPARATION AND PHENOTYPING OF THE TUMOR-HOST CELLULAR COMPARTMENTS IN TUMOR-BEARING NOD/SCID MICE. Neuro-Oncology. 10: 853-854.
  • Niclou, Simone P; Danzeisen, Claude; Brons, Nicolaas HC; Eikesdal, Hans Petter; Enger, Per Øyvind; Bjerkvig, Rolf. 2008. Complete separation and phenotyping of the tumor-host cellular compartments in tumor bearing nod/scid mice. Neuro-Oncology. 10: 1148-1148.
  • Niclou, Simone P; Danzeisen, Claude; Eikesdal, Hans Petter; Wiig, Helge; Brons, Nicolaas HC; Poli, Aurélie MF; Svendsen, Agnete; Torsvik, Anja; Enger, Per Øyvind; Terzis, Jorge A; Bjerkvig, Rolf. 2008. A novel eGFP-expressing immunodeficient mouse model to study tumor-host interactions. The FASEB Journal. 22: 3120-3128. doi: 10.1096/fj.08-109611
Reports and theses
  • Eikesdal, Hans Petter; Andersen, Knut-Jan. 1996. In vitro toksikologi på proximale tubuli celler. Medisinsk særoppgave, Universitetet i Bergen. 27 pages.
Book sections
  • Eikesdal, Hans Petter; Kalluri, Raghu. 2011. The multifaceted role of cancer associated fibroblasts in tumor progression. Chapter 19, pages 361-380. In:
    • Mueller, Margareta M.; Fusenig, Norbert E. 2011. Tumor-associated fibroblasts and their matrix. Springer. 452 pages. ISBN: 9789400706583.

More information in national current research information system (CRIStin)